BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 82920)

  • 1. [Significance of the contemporary determination of tumor associated antigens in patients with various types of neoplasms of the genital tract].
    Sacco F; Benedetti Panici P; Villani L; Di Roberto P; Barile G; Iacobelli S
    Minerva Ginecol; 1978 Oct; 30(10):811-6. PubMed ID: 82920
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological markers in gynecologic cancers. An overview.
    Dini MM; Miller M
    IMJ Ill Med J; 1984 Sep; 166(3):166-71. PubMed ID: 6208177
    [No Abstract]   [Full Text] [Related]  

  • 3. Oncofetal and oncoplacental antigens as tumor markers.
    Yamauchi S; Miyake H
    Kitasato Arch Exp Med; 1988 Sep; 61(2-3):95-109. PubMed ID: 2463397
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serum markers in malignant diseases].
    Peter HH
    Med Lab (Stuttg); 1981 Nov; 34(11):262-71. PubMed ID: 6176842
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
    Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumor markers in oncological gynecology].
    Vishnevskiĭ AS
    Vopr Onkol; 1984; 30(8):23-34. PubMed ID: 6207663
    [No Abstract]   [Full Text] [Related]  

  • 7. Antigens, enzymes and hormones. Their roles as tumor markers in gynecologic neoplasia.
    Fenoglio CM
    Diagn Gynecol Obstet; 1980; 2(1):33-42. PubMed ID: 6162629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and management of cancer using tumor markers].
    Torigoe T; Kato H
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Sep; 35(9):1672-6. PubMed ID: 6194233
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fetal and placental proteins in ovarian cancer].
    Tatra G; Ludwig H
    Gynakol Rundsch; 1980 Jun; 20 Suppl 2():138-41. PubMed ID: 6163685
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial: When is a tumor marker not a tumor marker?
    Vaitukaitis JL
    N Engl J Med; 1975 Dec; 293(26):1370-1. PubMed ID: 52844
    [No Abstract]   [Full Text] [Related]  

  • 11. Oncofetal antigens in ovarian cyst fluids.
    Kraly DH; Koh SH; Hay DL; Cauchi MN
    Gynecol Obstet Invest; 1984; 18(3):117-21. PubMed ID: 6208091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour markers in ovarian cancer.
    van Nagell JR
    Clin Obstet Gynaecol; 1983 Aug; 10(2):197-212. PubMed ID: 6193919
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumour antigens associated with primary mediastinal choriocarcinoma.
    Forest JC; Talbot J; Pagé M; Loiselle JM
    Can Med Assoc J; 1977 Dec; 117(12):1386-8. PubMed ID: 73406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic significance and clinical application of tumour-associated antigens in man with special reference to the carcinoembryonic antigen.
    Wagener C; Breuer H
    J Clin Chem Clin Biochem; 1977 Oct; 15(10):529-43. PubMed ID: 72783
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumour markers in the detection of gynaecological cancer.
    Atkinson RJ
    Br J Hosp Med; 1981 Oct; 26(4):381-2, 385-6. PubMed ID: 6171321
    [No Abstract]   [Full Text] [Related]  

  • 16. Radioimmunoassay and saturation analysis. Tumor-associated antigens.
    Bagshawe KD
    Br Med Bull; 1974 Jan; 30(1):68-73. PubMed ID: 4143181
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor markers in the ovarian carcinoma.
    Margariti PA; Benedetti Panici P; Villani L; Di Roberto P; Maiorca A; Sacco F; Bompiani A
    Eur J Gynaecol Oncol; 1980 May; 1(2):77-9. PubMed ID: 6174341
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunocytochemical evaluation of primary human esophageal carcinomas and their xenografts for keratin, beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL; Purnell DM; Combs JW; Valerio MG; Harris CC; Trump BF
    Cancer Res; 1986 Nov; 46(11):5730-7. PubMed ID: 2428482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical markers in gynaecological cancer.
    Farrell RJ
    Ir Med J; 1980 Aug; 73(8):285-6. PubMed ID: 6161106
    [No Abstract]   [Full Text] [Related]  

  • 20. [Course studies by means of tumor markers].
    Quentmeier A
    Aktuelle Probl Chir Orthop; 1980; 74():43-6. PubMed ID: 6156606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.